The PE Ratio as of December 2024 (TTM) for LAVA Therapeutics N.V. (LVTX) is -0.97

According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.97. This represents a change of -91.35% compared to the average of -11.22 of the last 4 quarters.

LAVA Therapeutics N.V. (LVTX) Historical PE Ratio (quarterly & annually)

How has LVTX PE Ratio performed in the past?

The mean historical PE Ratio of LAVA Therapeutics N.V. over the last ten years is -11.27. The current -0.97 PE Ratio has changed 760.52% with respect to the historical average. Over the past ten years (40 quarters), LVTX's PE Ratio was at its highest in in the September 2022 quarter at 31.55. The PE Ratio was at its lowest in in the March 2024 quarter at -40.82.

LAVA Therapeutics N.V. (LVTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of LAVA Therapeutics N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LAVA Therapeutics N.V. (LVTX) Average PE Ratio

How has LVTX PE Ratio performed in the past?

The current PE Ratio of LAVA Therapeutics N.V. (LVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

LAVA Therapeutics N.V. (LVTX) PE Ratio vs. Peers

How is LVTX’s PE Ratio compared to its peers?

LAVA Therapeutics N.V.’s PE Ratio is greater than Anebulo Pharmaceuticals, Inc. (-5.30), greater than PMV Pharmaceuticals, Inc. (-1.47), greater than Miromatrix Medical Inc. (-7.13), greater than ZIVO Bioscience, Inc. (-5.50), less than Bionomics Limited (-0.30), greater than Edgewise Therapeutics, Inc. (-22.36), greater than Ikena Oncology, Inc. (-1.24), greater than Design Therapeutics, Inc. (-7.53), greater than Xilio Therapeutics, Inc. (-1.16), less than Eliem Therapeutics, Inc. (0), less than Aerovate Therapeutics, Inc. (-0.89), greater than Adagene Inc. (-2.67), greater than Acrivon Therapeutics, Inc. Common Stock (-3.08), greater than Rezolute, Inc. (-4.44), less than AN2 Therapeutics, Inc. (-0.67), less than Generation Bio Co. (-0.49), less than Kronos Bio, Inc. (-0.67), greater than Erasca, Inc. (-4.56), greater than C4 Therapeutics, Inc. (-2.55), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than Instil Bio, Inc. (-1.89), less than Achilles Therapeutics plc (-0.69), less than NextCure, Inc. (-0.41), greater than Assembly Biosciences, Inc. (-2.29),

Build a custom stock screener for LAVA Therapeutics N.V. (LVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAVA Therapeutics N.V. (LVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.